We are live on ! Find out more
FSTX

F-star Therapeutics, Inc. Common Stock
FSTX

Delisted

FSTX was delisted on the 8th of March, 2023.

Back to rankings

51 hedge funds and large institutions have $84.6M invested in F-star Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

833% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 3

60% more capital invested

Capital invested by funds: $52.9M → $84.6M (+$31.8M)

2% less funds holding

Funds holding: 52 → 51 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

Holders
51
Holders Change
-1
Holders Change %
-1.92%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
28
Reduced
3
Closed
10
Calls
$2.41M
Puts
–
Net Calls
+$2.41M
Net Calls Change
+$40K

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$8.53M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$8.14M
3
BBA
Baker Bros. Advisors
New York
+$3.01M
4
SI
Sofinnova Investments
California
+$2.37M
5
BI
BVF Inc
California
+$2.1M

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$745K
2
Goldman Sachs
Goldman Sachs
New York
-$276K
3
CS
Candriam SCA
Luxembourg
-$237K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$183K
5
CWG
C WorldWide Group
Denmark
-$145K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$255K +$52.6K +1,051 +25%
CC
27
Caxton Corporation
New Jersey
$253K +$263K +5,247 New
LF
28
Lee Financial
Texas
$226K – – –
TCIM
29
TIAA CREF Investment Management
New York
$194K -$11.7K -233 -5%
TA
30
Teachers Advisors
New York
$163K – – –
JP Morgan Chase
31
JP Morgan Chase
New York
$153K +$131K +2,614 +463%
New York State Common Retirement Fund
32
New York State Common Retirement Fund
New York
$148K – – –
HP
33
Hikari Power
Japan
$137K +$142K +2,834 New
Wells Fargo
34
Wells Fargo
California
$125K +$11K +219 +9%
William Blair & Company
35
William Blair & Company
Illinois
$123K +$128K +2,556 New
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$122K +$127K +2,537 New
AIG
37
American International Group
New York
$112K +$25.9K +518 +29%
UBS Group
38
UBS Group
Switzerland
$82K +$48.9K +977 +135%
Barclays
39
Barclays
United Kingdom
$63K +$54.4K +1,087 +479%
Citigroup
40
Citigroup
New York
$46K +$33K +658 +214%
SO
41
STRS Ohio
Ohio
$38K – – –
Bank of America
42
Bank of America
North Carolina
$34K +$10.9K +217 +45%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$30K +$3.91K +78 +14%
Legal & General Group
44
Legal & General Group
United Kingdom
$28K +$8.36K +167 +41%
MAM
45
Meeder Asset Management
Ohio
$28K +$27K +539 +1,540%
AIP
46
Ameritas Investment Partners
Nebraska
$13K – – –
LTFS
47
Ladenburg Thalmann Financial Services
Florida
$7K +$1.25K +25 +20%
TRCT
48
Tower Research Capital (TRC)
New York
$7K +$7.76K +155 New
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$4.37K – – –
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$1K +$250 +5 +25%
1
2
3

FSTX Hedge Fund Activity: Q3 2018 in Review

51 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in F-star Therapeutics, Inc. Common Stock (FSTX) for Q3 2018, worth a combined $84.6M — up 60% from $52.9M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of FSTX and 9 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 28 added.

The largest buyer was Jennison Associates, opening a new position worth an estimated $8.53M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $745K sold.

  • 51 institutional investors held F-star Therapeutics, Inc. Common Stock (FSTX) as of Q3 2018, down from 52 in Q2 2018.
  • Funds reported $84.6M of F-star Therapeutics, Inc. Common Stock stock for Q3 2018, up 60% quarter-over-quarter.
  • 9 funds opened new F-star Therapeutics, Inc. Common Stock positions in Q3 2018 and 10 closed out, a net change of -1 holder.
  • The largest F-star Therapeutics, Inc. Common Stock buyer in Q3 2018 was Jennison Associates, an estimated $8.53M added.
  • The largest F-star Therapeutics, Inc. Common Stock seller in Q3 2018 was Alyeska Investment Group, an estimated $745K sold.

Based on aggregated 13F filings for Q3 2018.